Fig. 3

Effect of different concentrations of R428 on B-CPAP cell proliferation. The B-CPAP cell line was cultured and treated with the AXL inhibitor R428 at different concentrations (0.5 µmol/L, 1 µmol/L, 2 µmol/L, 4 µmol/L), and the untreated B-CPAP cell line was used as a control group. A CCK-8 assay was performed to assess the cell proliferation rate. The data shows that B-CPAP proliferation was suppressed by various concentrations of R428 (**p < 0.01 compared to the control group)